The evolving role of cardiac imaging in patients with myocardial infarction and non-obstructive coronary arteries

RA Montone, IK Jang, JF Beltrame, R Sicari… - Progress in …, 2021 - Elsevier
Myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) represents a
heterogeneous clinical conundrum accounting for about 6%–8% of all acute MI who are …

[HTML][HTML] The role of cardiac magnetic resonance in myocardial infarction and non-obstructive coronary arteries

K Liang, E Nakou, MG Del Buono… - Frontiers in …, 2022 - frontiersin.org
Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) accounts for 5-15%
of all presentations of acute myocardial infarction. The absence of obstructive coronary …

JCS/CVIT/JCC 2023 guideline focused update on diagnosis and treatment of vasospastic angina (coronary spastic angina) and coronary microvascular dysfunction

S Hokimoto, K Kaikita, S Yasuda, K Tsujita… - Circulation …, 2023 - jstage.jst.go.jp
In 2008, the Guidelines for diagnosis and treatment of patients with vasospastic angina
(coronary spastic angina) 1 were developed by the Japanese Circulation Society, and the …

[HTML][HTML] Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary …

RA Montone, R Rinaldi, MG Del Buono… - …, 2022 - ncbi.nlm.nih.gov
Background Intracoronary provocation testing with acetylcholine (ACh) is crucial for the
diagnosis of functional coronary alterations in patients with suspected myocardial ischaemia …

Safety of provocative testing with intracoronary acetylcholine and implications for standard protocols

T Takahashi, BA Samuels, W Li, MA Parikh… - Journal of the American …, 2022 - jacc.org
Background Heterogeneity in diagnostic criteria and provocation protocols has posed
challenges in understanding the safety of coronary provocation testing with intracoronary …

[HTML][HTML] Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the …

RA Montone, N Cosentino, F Graziani, R Gorla… - …, 2022 - ncbi.nlm.nih.gov
Myocardial infarction with non-obstructive coronary arteries (MINOCA) represents about 6-
8% of patients presenting with myocardial infarction (MI), and it is associated with a …

Air pollution and coronary vasomotor disorders in patients with myocardial ischemia and unobstructed coronary arteries

M Camilli, M Russo, R Rinaldi, A Caffè… - Journal of the American …, 2022 - jacc.org
Background Coronary vasomotor abnormalities are important causes of myocardial
ischemia in patients with nonobstructive coronary artery disease (NOCAD). However, the …

Update on coronary artery spasm 2022–a narrative review

A Seitz, VM Pereyra, U Sechtem, P Ong - International Journal of …, 2022 - Elsevier
Importance In today's era of precision medicine a renaissance of functional coronary
disease including coronary artery spasm (CAS) can be observed. This development is …

Update review on myocardial bridging: new insights

A Matta, J Roncalli, D Carrié - Trends in Cardiovascular Medicine, 2024 - Elsevier
Myocardial bridging (MB) is a common congenital abnormality that remains asymptomatic in
a large proportion of patients. The peak of clinical manifestation occurs during the third and …

Coronary microvascular dysfunction and myocardial infarction with non-obstructive coronary arteries: Where do we stand?

AQ Mohammed, FA Abdu, L Liu, G Yin… - European Journal of …, 2023 - Elsevier
In the past decade, scientific and clinical research has provided a translational perspective
on myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA). MINOCA is …